Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced Gastropathy

NCT00641004 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical, Inc., Philippines as lead sponsor.

NCT NCT00641004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00641004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced Gastropathy
Lead sponsor
Otsuka Pharmaceutical, Inc., Philippines
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2008
Completion date
March 31, 2010
Enrollment
30 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

nsaid induced gastropathy